205 related articles for article (PubMed ID: 12270175)
21. Synthesis and antitumor activity of novel diaryl ether hydroxamic acids derivatives as potential HDAC inhibitors.
Zhu Y; Chen X; Wu Z; Zheng Y; Chen Y; Tang W; Lu T
Arch Pharm Res; 2012 Oct; 35(10):1723-32. PubMed ID: 23139122
[TBL] [Abstract][Full Text] [Related]
22. Design and synthesis of a new generation of substituted purine hydroxamate analogs as histone deacetylase inhibitors.
Liu R; Wang J; Tang W; Fang H
Bioorg Med Chem; 2016 Apr; 24(7):1446-54. PubMed ID: 26907204
[TBL] [Abstract][Full Text] [Related]
23. Bicyclic peptides as potent inhibitors of histone deacetylases: optimization of alkyl loop length.
Islam NM; Kato T; Nishino N; Kim HJ; Ito A; Yoshida M
Bioorg Med Chem Lett; 2010 Feb; 20(3):997-9. PubMed ID: 20045316
[TBL] [Abstract][Full Text] [Related]
24. Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
Hieu DT; Anh DT; Hai PT; Huong LT; Park EJ; Choi JE; Kang JS; Dung PTP; Han SB; Nam NH
Chem Biodivers; 2018 Jun; 15(6):e1800027. PubMed ID: 29667768
[TBL] [Abstract][Full Text] [Related]
25. Synthesis of 7200 small molecules based on a substructural analysis of the histone deacetylase inhibitors trichostatin and trapoxin.
Sternson SM; Wong JC; Grozinger CM; Schreiber SL
Org Lett; 2001 Dec; 3(26):4239-42. PubMed ID: 11784187
[TBL] [Abstract][Full Text] [Related]
26. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif.
Guan P; Wang L; Hou X; Wan Y; Xu W; Tang W; Fang H
Bioorg Med Chem; 2014 Nov; 22(21):5766-75. PubMed ID: 25311567
[TBL] [Abstract][Full Text] [Related]
27. Discovery of pyrimidyl-5-hydroxamic acids as new potent histone deacetylase inhibitors.
Angibaud P; Arts J; Van Emelen K; Poncelet V; Pilatte I; Roux B; Van Brandt S; Verdonck M; De Winter H; Ten Holte P; Marien A; Floren W; Janssens B; Van Dun J; Aerts A; Van Gompel J; Gaurrand S; Queguiner L; Argoullon JM; Van Hijfte L; Freyne E; Janicot M
Eur J Med Chem; 2005 Jun; 40(6):597-606. PubMed ID: 15922843
[TBL] [Abstract][Full Text] [Related]
28. N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression.
Mehndiratta S; Lin MH; Wu YW; Chen CH; Wu TY; Chuang KH; Chao MW; Chen YY; Pan SL; Chen MC; Liou JP
Eur J Med Chem; 2020 Jan; 185():111725. PubMed ID: 31655430
[TBL] [Abstract][Full Text] [Related]
29. Quinazolin-4(3H)-one-Based Hydroxamic Acids: Design, Synthesis and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
Hieu DT; Anh DT; Hai PT; Thuan NT; Huong LT; Park EJ; Young Ji A; Soon Kang J; Phuong Dung PT; Han SB; Nam NH
Chem Biodivers; 2019 Apr; 16(4):e1800502. PubMed ID: 30653817
[TBL] [Abstract][Full Text] [Related]
30. Exploring bis-(indolyl)methane moiety as an alternative and innovative CAP group in the design of histone deacetylase (HDAC) inhibitors.
Giannini G; Marzi M; Marzo MD; Battistuzzi G; Pezzi R; Brunetti T; Cabri W; Vesci L; Pisano C
Bioorg Med Chem Lett; 2009 May; 19(10):2840-3. PubMed ID: 19359173
[TBL] [Abstract][Full Text] [Related]
31. Structurally simple trichostatin A-like straight chain hydroxamates as potent histone deacetylase inhibitors.
Woo SH; Frechette S; Abou Khalil E; Bouchain G; Vaisburg A; Bernstein N; Moradei O; Leit S; Allan M; Fournel M; Trachy-Bourget MC; Li Z; Besterman JM; Delorme D
J Med Chem; 2002 Jun; 45(13):2877-85. PubMed ID: 12061890
[TBL] [Abstract][Full Text] [Related]
32. Novel inhibitors of human histone deacetylases: design, synthesis, enzyme inhibition, and cancer cell growth inhibition of SAHA-based non-hydroxamates.
Suzuki T; Nagano Y; Kouketsu A; Matsuura A; Maruyama S; Kurotaki M; Nakagawa H; Miyata N
J Med Chem; 2005 Feb; 48(4):1019-32. PubMed ID: 15715470
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological characterization of amidopropenyl hydroxamates as HDAC inhibitors.
Thaler F; Varasi M; Colombo A; Boggio R; Munari D; Regalia N; Rozio MG; Reali V; Resconi AE; Mai A; Gagliardi S; Dondio G; Minucci S; Mercurio C
ChemMedChem; 2010 Aug; 5(8):1359-72. PubMed ID: 20572281
[TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationship studies of novel oxygen-incorporated SAHA analogues.
Kim SA; Jin YL; Kim HS
Arch Pharm Res; 2009 Jan; 32(1):15-21. PubMed ID: 19183872
[TBL] [Abstract][Full Text] [Related]
35. Development of potential antitumor agents. Synthesis and biological evaluation of a new set of sulfonamide derivatives as histone deacetylase inhibitors.
Bouchain G; Leit S; Frechette S; Khalil EA; Lavoie R; Moradei O; Woo SH; Fournel M; Yan PT; Kalita A; Trachy-Bourget MC; Beaulieu C; Li Z; Robert MF; MacLeod AR; Besterman JM; Delorme D
J Med Chem; 2003 Feb; 46(5):820-30. PubMed ID: 12593661
[TBL] [Abstract][Full Text] [Related]
36. Simple inhibitors of histone deacetylase activity that combine features of short-chain fatty acid and hydroxamic acid inhibitors.
Tischler JL; Abuaita B; Cuthpert SC; Fage C; Murphy K; Saxe A; Furr EB; Hedrick J; Meyers J; Snare D; Zand AR
J Enzyme Inhib Med Chem; 2008 Aug; 23(4):549-55. PubMed ID: 18608778
[TBL] [Abstract][Full Text] [Related]
37. Carbamates as Potential Prodrugs and a New Warhead for HDAC Inhibition.
King K; Hauser AT; Melesina J; Sippl W; Jung M
Molecules; 2018 Feb; 23(2):. PubMed ID: 29393896
[TBL] [Abstract][Full Text] [Related]
38. Isoform-selective histone deacetylase inhibitors.
Bieliauskas AV; Pflum MK
Chem Soc Rev; 2008 Jul; 37(7):1402-13. PubMed ID: 18568166
[TBL] [Abstract][Full Text] [Related]
39. Diphenylmethylene hydroxamic acids as selective class IIa histone deacetylase inhibitors.
Tessier P; Smil DV; Wahhab A; Leit S; Rahil J; Li Z; Déziel R; Besterman JM
Bioorg Med Chem Lett; 2009 Oct; 19(19):5684-8. PubMed ID: 19699639
[TBL] [Abstract][Full Text] [Related]
40. Synthesis of rigid trichostatin A analogs as HDAC inhibitors.
Charrier C; Bertrand P; Gesson JP; Roche J
Bioorg Med Chem Lett; 2006 Oct; 16(20):5339-44. PubMed ID: 16904890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]